/Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (inhbe) Inhibitors
Abstract
The present disclosure provides methods of treating a subject having metabolic disorders and/or cardiovascular diseases, methods of identifying subjects having an increased risk of developing a metabolic disorder and/or a cardiovascular disease, and methods of detecting human Inhibin Subunit Beta E variant nucleic acid molecules and variant polypeptides.
Full Text
What is claimed is:
The present disclosure provides methods of treating a subject having metabolic disorders and/or cardiovascular diseases, methods of identifying subjects having an increased risk of developing a metabolic disorder and/or a cardiovascular disease, and methods of detecting human Inhibin Subunit Beta E variant nucleic acid molecules and variant polypeptides.
Timeline
Filed
03/25/2026Published
07/09/2026Granted
Not AvailableIPC Codes(8)
A61K 31/7105:Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
A61K 31/7088:Compounds having three or more nucleosides or nucleotides
A61K 31/713:Double-stranded nucleic acids or oligonucleotides